May. 16 at 7:13 PM
$SLS it is inevitable - the 80th Event PR is coming, Phase 3 Registrational Results and FDA Green light worth
$40B to big Pharma - are Coming.
ANY - DAY - NOW GPS P3 Results - truly worth
$40B + the Instant the REGAL Results are announced
- GPS MOS 30-36 months, BAT 8-10 --- T1 Trading Halt - Gap Up into the
$10B MCap Range /
$50 Per Share - AND CLIMBING
And to Bottom LINE 009 / TAMBICICLIB Will Be FDA Approved - the Market Has yet to appreciate its value.
Gleevc - Imatinib, Imbrutinib - Imbruvica, Upadactinib - Rinvoq Upadactinib <- say that 3 x fast
$PFE Pfizers' Ibrance - Palbociclib CDKinase Inhibitor
Novartis' Kisqali -Ribociclib CDKinase Inhibitor
$LLY Eli Lilly's Verzenio - Abemaciclib CDKinase Inhibitor
$SLS Tambiciclib CDKInase Inhibitor
reddit.com/r/sellasLifescience ... for anyone interested in DD/ i been here -invested a long time/ if you have an interest in $